Relmacabtagene Autoleucel in Patients With LBCL

Clinical trial NCT06142175 · UNKNOWN

Trial details

NCT number: NCT06142175
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Large B-cell Lymphoma

Start date: 2022-12-28
Primary completion: 2024-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.